Hong Jae Chon: Integrating Systemic Therapy in the Earlier Stages of Liver Cancer
4h agoen
From the article
Hong Jae Chon, Director of Cancer Center, CHA Bundang Medical Center, shared a post on X: “ICI moving to earlier stage of primary liver cancer Journal of Hepatology. TACE + ICI: […]
Continue reading on OncoDailyYou might also wanna read
Traitements contre le cancer : «La Chine est en train de devenir le leader mondial du médicament»
l.liberation.fr·1mo ago
Alternative Therapy for Liver Cancer in Mexico
ltcnews.com·2y ago
ネコの腎臓病治療薬が承認申請段階に、ヒト用も早期治験へ—AIM医学研究所
AIM医学研究所の宮崎徹所長が開発を主導するネコの腎臓病治療薬が実用化の最終段階に入り、4月に農林水産省へ製造販売の承認申請が提出された。この治療薬は血液中のタンパク質「AIM」に着目し、ネコでも機能するAIMを注入することで腎臓の老廃物除去を促進する。治験では末期に近い慢性腎臓
jiji.com·1mo ago市场监管总局多举措整治“内卷式”竞争
36氪·1d ago
Silent Threat: Fatty Liver Disease Linked to Cancer, Dementia Risk
ltcnews.com·2y ago
The Interconnection Between Mental Health and Metabolic Health: A Case for Integrated Care
This article from Harvard Medical School explores the deep interconnection between mental health and metabolic health, emphasizing that ment
learn.hms.harvard.edu·19d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.